nodes	percent_of_prediction	percent_of_DWPC	metapath
Fulvestrant—Injection site haematoma—Octreotide—thymus cancer	0.21	0.305	CcSEcCtD
Fulvestrant—Gastrointestinal symptom NOS—Octreotide—thymus cancer	0.0336	0.0489	CcSEcCtD
Fulvestrant—NR1H4—hematopoietic system—thymus cancer	0.0274	0.0877	CbGeAlD
Fulvestrant—Injection site pain—Octreotide—thymus cancer	0.0242	0.0352	CcSEcCtD
Fulvestrant—Injection site reaction—Octreotide—thymus cancer	0.0196	0.0286	CcSEcCtD
Fulvestrant—EPHX2—pituitary gland—thymus cancer	0.0177	0.0568	CbGeAlD
Fulvestrant—ESR2—neck—thymus cancer	0.0169	0.0541	CbGeAlD
Fulvestrant—ESRRA—cardiac atrium—thymus cancer	0.0159	0.051	CbGeAlD
Fulvestrant—Injury—Octreotide—thymus cancer	0.0156	0.0227	CcSEcCtD
Fulvestrant—ESRRA—pituitary gland—thymus cancer	0.0155	0.0498	CbGeAlD
Fulvestrant—Hot flush—Octreotide—thymus cancer	0.0153	0.0223	CcSEcCtD
Fulvestrant—EPHX2—thyroid gland—thymus cancer	0.0153	0.049	CbGeAlD
Fulvestrant—Menopausal symptoms—Octreotide—thymus cancer	0.0152	0.0221	CcSEcCtD
Fulvestrant—Arthritis—Octreotide—thymus cancer	0.0148	0.0215	CcSEcCtD
Fulvestrant—Pain in extremity—Octreotide—thymus cancer	0.0143	0.0209	CcSEcCtD
Fulvestrant—EPHX2—lung—thymus cancer	0.0139	0.0445	CbGeAlD
Fulvestrant—ESRRA—bone marrow—thymus cancer	0.0134	0.043	CbGeAlD
Fulvestrant—ESRRA—thyroid gland—thymus cancer	0.0134	0.0429	CbGeAlD
Fulvestrant—ESR2—hematopoietic system—thymus cancer	0.0126	0.0403	CbGeAlD
Fulvestrant—Influenza—Octreotide—thymus cancer	0.0124	0.018	CcSEcCtD
Fulvestrant—ESRRA—lung—thymus cancer	0.0122	0.039	CbGeAlD
Fulvestrant—ESR1—neck—thymus cancer	0.0116	0.0371	CbGeAlD
Fulvestrant—ESR2—epithelium—thymus cancer	0.0115	0.0368	CbGeAlD
Fulvestrant—Depression—Octreotide—thymus cancer	0.011	0.016	CcSEcCtD
Fulvestrant—NR1H4—lymph node—thymus cancer	0.0109	0.0348	CbGeAlD
Fulvestrant—Urinary tract infection—Octreotide—thymus cancer	0.0107	0.0156	CcSEcCtD
Fulvestrant—Hepatobiliary disease—Octreotide—thymus cancer	0.0105	0.0152	CcSEcCtD
Fulvestrant—Hepatitis—Octreotide—thymus cancer	0.00992	0.0144	CcSEcCtD
Fulvestrant—Pharyngitis—Octreotide—thymus cancer	0.00985	0.0143	CcSEcCtD
Fulvestrant—Oedema peripheral—Octreotide—thymus cancer	0.00977	0.0142	CcSEcCtD
Fulvestrant—EPHX2—lymph node—thymus cancer	0.0095	0.0304	CbGeAlD
Fulvestrant—ESR2—pituitary gland—thymus cancer	0.00933	0.0299	CbGeAlD
Fulvestrant—Immune system disorder—Octreotide—thymus cancer	0.00896	0.013	CcSEcCtD
Fulvestrant—ESR2—lymphoid tissue—thymus cancer	0.00885	0.0284	CbGeAlD
Fulvestrant—Malnutrition—Octreotide—thymus cancer	0.00864	0.0126	CcSEcCtD
Fulvestrant—ESR1—hematopoietic system—thymus cancer	0.00861	0.0276	CbGeAlD
Fulvestrant—Back pain—Octreotide—thymus cancer	0.00835	0.0121	CcSEcCtD
Fulvestrant—ESRRA—lymph node—thymus cancer	0.00832	0.0267	CbGeAlD
Fulvestrant—ESR2—thyroid gland—thymus cancer	0.00804	0.0258	CbGeAlD
Fulvestrant—Anaemia—Octreotide—thymus cancer	0.00798	0.0116	CcSEcCtD
Fulvestrant—ESR1—epithelium—thymus cancer	0.00787	0.0252	CbGeAlD
Fulvestrant—Vertigo—Octreotide—thymus cancer	0.00776	0.0113	CcSEcCtD
Fulvestrant—Cough—Octreotide—thymus cancer	0.00754	0.011	CcSEcCtD
Fulvestrant—Chest pain—Octreotide—thymus cancer	0.00735	0.0107	CcSEcCtD
Fulvestrant—Myalgia—Octreotide—thymus cancer	0.00735	0.0107	CcSEcCtD
Fulvestrant—Arthralgia—Octreotide—thymus cancer	0.00735	0.0107	CcSEcCtD
Fulvestrant—Anxiety—Octreotide—thymus cancer	0.00733	0.0107	CcSEcCtD
Fulvestrant—ESR2—lung—thymus cancer	0.0073	0.0234	CbGeAlD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.0073	0.0106	CcSEcCtD
Fulvestrant—Infection—Octreotide—thymus cancer	0.007	0.0102	CcSEcCtD
Fulvestrant—Nervous system disorder—Octreotide—thymus cancer	0.00691	0.0101	CcSEcCtD
Fulvestrant—Skin disorder—Octreotide—thymus cancer	0.00685	0.00995	CcSEcCtD
Fulvestrant—Hyperhidrosis—Octreotide—thymus cancer	0.00681	0.00991	CcSEcCtD
Fulvestrant—Anorexia—Octreotide—thymus cancer	0.00672	0.00977	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00642	0.00934	CcSEcCtD
Fulvestrant—ESR1—pituitary gland—thymus cancer	0.00639	0.0205	CbGeAlD
Fulvestrant—Insomnia—Octreotide—thymus cancer	0.00638	0.00927	CcSEcCtD
Fulvestrant—Paraesthesia—Octreotide—thymus cancer	0.00633	0.0092	CcSEcCtD
Fulvestrant—Dyspnoea—Octreotide—thymus cancer	0.00628	0.00914	CcSEcCtD
Fulvestrant—Dyspepsia—Octreotide—thymus cancer	0.0062	0.00902	CcSEcCtD
Fulvestrant—Decreased appetite—Octreotide—thymus cancer	0.00613	0.00891	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Octreotide—thymus cancer	0.00609	0.00885	CcSEcCtD
Fulvestrant—Fatigue—Octreotide—thymus cancer	0.00608	0.00884	CcSEcCtD
Fulvestrant—ESR1—lymphoid tissue—thymus cancer	0.00606	0.0194	CbGeAlD
Fulvestrant—Pain—Octreotide—thymus cancer	0.00603	0.00876	CcSEcCtD
Fulvestrant—Constipation—Octreotide—thymus cancer	0.00603	0.00876	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Octreotide—thymus cancer	0.00576	0.00838	CcSEcCtD
Fulvestrant—Urticaria—Octreotide—thymus cancer	0.0056	0.00814	CcSEcCtD
Fulvestrant—Abdominal pain—Octreotide—thymus cancer	0.00557	0.0081	CcSEcCtD
Fulvestrant—Body temperature increased—Octreotide—thymus cancer	0.00557	0.0081	CcSEcCtD
Fulvestrant—ESR1—thyroid gland—thymus cancer	0.00551	0.0176	CbGeAlD
Fulvestrant—Hypersensitivity—Octreotide—thymus cancer	0.00519	0.00755	CcSEcCtD
Fulvestrant—Asthenia—Octreotide—thymus cancer	0.00506	0.00735	CcSEcCtD
Fulvestrant—ESR1—lung—thymus cancer	0.005	0.016	CbGeAlD
Fulvestrant—ESR2—lymph node—thymus cancer	0.005	0.016	CbGeAlD
Fulvestrant—Pruritus—Octreotide—thymus cancer	0.00499	0.00725	CcSEcCtD
Fulvestrant—Diarrhoea—Octreotide—thymus cancer	0.00482	0.00701	CcSEcCtD
Fulvestrant—CYP3A4—hematopoietic system—thymus cancer	0.00481	0.0154	CbGeAlD
Fulvestrant—Dizziness—Octreotide—thymus cancer	0.00466	0.00678	CcSEcCtD
Fulvestrant—Vomiting—Octreotide—thymus cancer	0.00448	0.00652	CcSEcCtD
Fulvestrant—Rash—Octreotide—thymus cancer	0.00444	0.00646	CcSEcCtD
Fulvestrant—Dermatitis—Octreotide—thymus cancer	0.00444	0.00646	CcSEcCtD
Fulvestrant—Headache—Octreotide—thymus cancer	0.00442	0.00642	CcSEcCtD
Fulvestrant—Nausea—Octreotide—thymus cancer	0.00419	0.00609	CcSEcCtD
Fulvestrant—ESR1—lymph node—thymus cancer	0.00342	0.011	CbGeAlD
